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Proteomic Approach and Health Promotion 
 
    For over a decade, applied proteomic researches in human health focused on the development and 
application of proteomic tools to promote the prediction, prevention and treatment of human diseases. 
Human Proteome Organization (HUPO) focused on global collaboration in major proteomic projects by 
gathering international laboratories. The scientific objectives of Human Proteome Project (HPP) include 
sampling and banking, antibody banking, expression profiling, modification profiling, protein linkage 
mapping, bioinformatics, and so on. Brain- HPP stablished on understanding protein expression in 
different parts of brain, neurodegenerative diseases and aging. Cancer-HPP follows the procedure to 
accrue a list of target proteins from each cancer type and strategy for assay development. Liver -HPP has 
investigated the proteomes of fetal liver tissues and adult liver tissues. HUPO also supported stem cell 
proteomics that may discover tremendous potential to develop treatments of diseases especially in the area of 
regenerative medicine. In addition, HPP supports large-scale proteomic projects related to cardiovascular, 
diabetes, EyeOME and kidney diseases. Many new biomarkers were introduced for cardiovascular disease and 
stroke, psychiatric disorders such as schizophrenia, neurodegenerative diseases such as Alzheimer's disease and 
kidney disease. Genomic and proteomic technologies are developed to identify, classify and 
improvements in treatment of autoimmune patients. Because of different protein expression in the 
amniotic infection, biomarker discovery in the amniotic fluid and serum may be helpful in early 
diagnosis. Proteomic methods and tools used in the research laboratory has become an increasingly 
popular method in the clinic. Beside on technology development, this also needs to set up standard 
operating procedures and optimize the strategies for proteome analysis. In addition, identification of 
protein drug targets is an important research program in pharmaceutics. Dynamic nature of proteome and 
lack of standard guidelines for laboratory work led to diversity in the proteome identification in the 
different laboratories. It seems that application of standard materials and procedures enable accurately 
identification and quantification of proteins in a various laboratories. Finally, proteomic approach can be 
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